Clinical Trial Update: Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. [Phase 3]

View source ↗

Summary

A phase 3 randomized trial compares safety and efficacy of dexmedetomidine versus midazolam in pediatric ICU patients beyond 24 hours.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Failure of Extubation
• Withdrawal Symptoms

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Midazolam (Midazolam)

Snippet

Sponsor: King Abdullah International Medical Research Center | Conditions: Dexmedetomidine, Midazolam | Phase 3 | Status: UNKNOWN